These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32432747)

  • 1. MicroRNA-149 inhibits the progression of lung adenocarcinoma through targeting RAP1B and inactivating Wnt/β-catenin pathway.
    Jiang WS; Huang CL; Zhang J; Xu F; Dai XH
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4846-4854. PubMed ID: 32432747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathway.
    Yao Y; Hua Q; Zhou Y
    Biochem Biophys Res Commun; 2019 Jan; 508(1):37-45. PubMed ID: 30470570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-204 targets SOX4 to inhibit metastasis of lung adenocarcinoma.
    Hu WB; Wang L; Huang XR; Li F
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1553-1562. PubMed ID: 30840278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-365 inhibits the progression of lung adenocarcinoma through targeting ETS1 and inactivating AKT/mTOR pathway.
    Tong L; Han WZ; Wang JL; Sun NN; Zhuang M
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4836-4845. PubMed ID: 32432746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
    Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
    Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
    [No Abstract]   [Full Text] [Related]  

  • 6. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
    Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
    Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
    Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
    Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of lncRNA ZFAS1 promotes lung adenocarcinoma progression by sponging miR-1271-5p and upregulating FRS2.
    Fan G; Jiao J; Shen F; Chu F
    Thorac Cancer; 2020 Aug; 11(8):2178-2187. PubMed ID: 32515146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-495 inhibits the progression of non-small-cell lung cancer by targeting TCF4 and inactivating Wnt/β-catenin pathway.
    Zheng HE; Wang G; Song J; Liu Y; Li YM; Du WP
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7750-7759. PubMed ID: 30536319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-449b-5p inhibits human glioblastoma cell proliferation by inactivating WNT2B/Wnt/β-catenin signaling pathway.
    Hou WZ; Chen XL; Qin LS; Xu ZJ; Liao GM; Chen D; Hu LJ; Mao ZM; -S Huang J; Yuan Q; Liao C; Yao QM
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5549-5557. PubMed ID: 32495889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/β-catenin pathway.
    Li W; Wang J; Zhang D; Zhang X; Xu J; Zhao L
    Cancer Biomark; 2019; 25(1):79-88. PubMed ID: 31033463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer.
    Bai D; Sun H; Wang X; Lou H; Zhang J; Wang X; Jiang L
    Med Sci Monit; 2017 Oct; 23():4885-4894. PubMed ID: 29023429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
    Xuan YW; Liao M; Zhai WL; Peng LJ; Tang Y
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8411-8421. PubMed ID: 31646571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway.
    Xi M; Cheng L; Hua W; Zhou YL; Gao QL; Yang JX; Qi SY
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1002-1011. PubMed ID: 30779066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAP1B, a DVL2 binding protein, activates Wnt/beta-catenin signaling in esophageal squamous cell carcinoma.
    Jia Z; Yang Y; Dengyan Z; Chunyang Z; Donglei L; Kai W; Song Z
    Gene; 2017 May; 611():15-20. PubMed ID: 28119087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-215 promoted the progression of nasopharyngeal carcinoma through targeting RB1 and activating Wnt/β-catenin pathway.
    Zhang Y; Zhang H; Li X
    J BUON; 2020; 25(3):1579-1586. PubMed ID: 32862607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
    Zhang Z; Yang Y; Zhang X
    Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
    Yang S; Li X; Shen W; Hu H; Li C; Han G
    J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.